skip to content
   

           
           OUR CLIENTS INCLUDE:

Aastrom Biosciences
Abbott Vascular
ActivBiotics
Advanced Biohealing
AngioScore
ANS (St. Jude Medical)
AtheroMed, Inc.
Bain & Company
Bard
Baxter
Bayer
BioMarin Pharmaceutical
Boston Scientific
Cardiovascular Systems, Inc.
Chemo France
CoDa Therapeutics, Inc.
Cordis (Johnson & Johnson Pharmaceuticals)
Cook Medical
Diffusion Pharmaceuticals LLC
Diomed Inc.
Edwards Lifesciences
ev3
FoxHollow Technologies
GlaxoSmithKline
Harvest Technologies
IDev Technologies
Indigo Pharmaceuticals
Infoucs Research
Intact Vascular
Jihad Mustapha MD
Joan Piesinger & Associates
Kerberos Proximal Solution
King Pharmaceuticals
Maxis
Medtronic
Novadaq Technologies
Nuvelo Inc.
OmniSonics Medical Technologies
Pathway Medical Technologies
Pluristem Therapeutics Inc.
Possis Medical
Rapid Medical
Sanofi-Aventis
Schering-Plough Corp.
Shire Pharmaceutical Group
Solvay Pharmaceuticals
Spectranetics Corporation
Stereotaxis
Straub Medical AG
Terumo
The Medicines Company
Thermogenesis Corp.
ThromboGenics Ltd.
W. L. Gore

According to
THE SAGE GROUP:

The prevalence of peripheral artery disease (PAD) in the U.S. is much higher than the commonly cited figures of 8-12 million.

Research published by THE SAGE GROUP indicates that 20 million people in the U.S. had PAD in 2015. With the ageing population, this number is projected to exceed 24 million by 2030.

 

Powered by Website Baker, design by Atlanta Based MaxxWebs Design and Development